Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers

Gastroenterology

Volumn 135, Issue 3, 2008, Pages

  Endo, Yoko ^a   Marusawa, Hiroyuki ^a   Kou, Tadayuki ^a   Nakase, Hiroshi ^a   Fujii, Shigehiko ^b   Fujimori, Takahiro ^b   Kinoshita, Kazuo ^c   Honjo, Tasuku ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Dept Pediat Shiga Med Ctr C   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 51249087746     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.06.091     Document Type: Article

References (49)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Gyde S.N., Prior P., Allan R.N., et al. Colorectal cancer in ulcerative colitis. Gut 29 (1988) 206-217
3. Mellemkjaer L., Olsen J.H., Frisch M., et al. Cancer in patients with ulcerative colitis. Int J Cancer 60 (1995) 330-333
4. Kiesslich R., Goetz M., Lammersdorf K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132 (2007) 874-882
5. Yin J., Harpaz N., Tong Y., et al. p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104 (1993) 1633-1639
6. Kern S.E., Redston M., Seymour A.B., et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107 (1994) 420-428
7. Kou T., Marusawa H., Kinoshita K., et al. Expression of AID in human hepatocytes during hepatocarcinogenesis. Int J Cancer 120 (2007) 469-476
8. Endo Y., Marusawa H., Kinoshita K., et al. Expression of AID in human hepatocytes via NF-κB signaling. Oncogene 26 (2007) 5587-5595
9. Matsumoto Y., Marusawa H., Kinoshita K., et al. Helicobacter pylori infection triggers aberrant expression of AID in gastric epithelium. Nat Med 13 (2007) 470-476
10. Muramatsu M., Kinoshita K., Fagarasan S., et al. Class switch recombination and hypermutation require AID, a potential RNA editing enzyme. Cell 102 (2000) 553-563
11. Honjo T., Kinoshita K., and Muramatsu M. Molecular mechanism of class switch recombination. Annu Rev Immunol 20 (2002) 165-196
12. Kinoshita K., and Nonaka T. The dark side of AID: relationship with leukemia and beyond. Int J Hematol 83 (2006) 201-207
13. Okazaki I.M., Hiai H., Kakazu N., et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 197 (2003) 1173-1181
14. Kotani A., Okazaki I.M., Muramatsu M., et al. A target selection of somatic hypermutations is regulated similarly between T and B cells upon AID expression. Proc Natl Acad Sci U S A 102 (2005) 4506-4511
15. Szlosarek P.W., and Balkwill F.R. TNF-α: a potential target for the therapy of solid tumours. Lancet Oncol 4 (2003) 565-573
16. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117 (2007) 1175-1183
17. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 390-407
18. Marusawa H., Hijikata M., Watashi K., et al. Regulation of Fas-mediated apoptosis by NF-κB activity in human hepatocyte derived cell lines. Microbiol Immunol 45 (2001) 483-489
19. Mikita T., Campbell D., Wu P., et al. Requirements for IL-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol 16 (1996) 5811-5820
20. Fagarasan S., Kinoshita K., Muramatsu M., et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413 (2001) 639-643
21. Bransteitter R., Pham P., Calabrese P., et al. Biochemical analysis of hypermutational targeting by wild type and mutant AID. J Biol Chem 279 (2004) 51612-51621
22. Ta V.T., Nagaoka H., Catalan N., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4 (2003) 843-848
23. Toda Y., Kono K., Abiru H., et al. Application of tyramide signal amplification system to immunohistochemistry. Pathol Int 49 (1999) 479-483
24. Rogler G., Brand K., Vogl D., et al. NF-κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115 (1998) 357-369
25. Diaz-Meco M.T., Dominguez I., Sanz L., et al. zeta PKC induces phosphorylation and inactivation of IκB-α in vitro. EMBO J 13 (1994) 2842-2848
26. Dedeoglu F., Horwitz B., Chaudhuri J., et al. Induction of AID gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NF-κB. Int Immunol 16 (2004) 395-404
27. Inoue S., Matsumoto T., Iida M., et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis. Am J Gastroenterol 94 (1999) 2441-2446
28. Takeda K., Tanaka T., Shi W., et al. Essential role of Stat6 in IL-4 signalling. Nature 380 (1996) 627-630
29. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
30. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17 (2006) 173-188
31. Bhan A.K., Mizoguchi E., Smith R.N., et al. Spontaneous chronic colitis in TCR-α mutant mice; an experimental model of human ulcerative colitis. Int Rev Immunol 19 (2000) 123-138
32. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
33. Fuss I.J., Neurath M., Boirivant M., et al. Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease. J Immunol 157 (1996) 1261-1270
34. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
35. Heller F., Fuss I.J., Nieuwenhuis E.E., et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17 (2002) 629-638
36. Fuss I.J., Heller F., Boirivant M., et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113 (2004) 1490-1497
37. Osawa E., Nakajima A., Fujisawa T., et al. Predominant Th2-inflammatory responses promote murine colon cancers. Int J Cancer 118 (2006) 2232-2236
38. Karin M. NF-κB in cancer development and progression. Nature 441 (2006) 431-436
39. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2 (1996) 998-1004
40. Greten F.R., Eckmann L., Greten T.F., et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
41. Itzkowitz S.H., and Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126 (2004) 1634-1648
42. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
43. Chung D.C. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119 (2000) 854-865
44. Lashner B.A., Shapiro B.D., Husain A., et al. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol 94 (1999) 456-462
45. Hussain S.P., Amstad P., Raja K., et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis. Cancer Res 60 (2000) 3333-3337
46. Ramiro A.R., Stavropoulos P., Jankovic M., et al. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat Immunol 4 (2003) 452-456
47. Chaudhuri J., Tian M., Khuong C., et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422 (2003) 726-730
48. Fagarasan S., Muramatsu M., Suzuki K., et al. Critical roles of AID in the homeostasis of gut flora. Science 298 (2002) 1424-1427
49. Verdu E.F., Bercik P., Cukrowska B., et al. Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice. Clin Exp Immunol 120 (2000) 46-50